Rinatabart sesutecan Antibody
Rinatabart sesutecan is a highly homogeneous antibody-drug conjugate (ADC) targeting folate receptor alpha (FRα) . Rinatabart sesutecan consists of a humanized antibody targeting FRα, a hydrophilic cleavable linker, and the topoisomerase I inhibitor exatecan as the payload. It is primarily used for the targeted treatment and mechanistic research of folate receptor-positive solid tumors.
Product Specifications
Target
Antifolate, Antibody-Drug Conjugates (ADCs)
Conjugation
Unconjugated
Concentration
8.77 mg/mL
Purity
95.00% (May vary between batches)
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470679-500 1x 500 µL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940009-500 1x 500 µL
MART-1 / Melan-A (M2-7C10), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC882175-500 1x 500 µL
Cytokeratin 8 (KRT8) (rB22.1), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details